1. All of the plaintiff's claims are dismissed.

2. The costs of lawsuit shall be borne by the Plaintiff.

1. Basic facts

A. Personal relations 1) The Plaintiff (hereinafter “Plaintiff Company”) is also the Plaintiff.

) The company is mainly engaged in the development, manufacture, and sales of biological medicine, cosmetics (see Evidence A No. 1-1-2). 2) The Plaintiff company and C Co., Ltd. [the affiliate company of this company is the Defendant Company (hereinafter “Defendant Company”).

The rights and obligations of the Company in relation to the instant case were transferred to the Defendant Company on December 31, 2005 (see, e.g., Article 2 of the preparatory brief dated September 18, 2018). The Company’s disclosure to be made by the Defendant Company is jointly made by using the cost fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluoral fluor fluor fluor fluor fluor fluor fluor fluor fluor fluor fluor fluor fluor f).

(See Evidence A No. 18-1 and Evidence A No. 3-1). The name of the invention: It includes the separation of hirropic acid from the quantity obtained by cultivating I of the Pirretoccocus SP. (SP.) of the H claims 1, referred to in Article 97 of the Patent Act, which is referred to in Article 97 of the Patent Act (excluding the part stated in the attached patent right, to be integrated and publicly stated as “hiropic acid 1”). The Cirretocus sptocus sptocus sptocus spus sp. sp. sp.) sp. 2, which includes the separation of hiropic acid spretocus sptocus sp. (Stretocus sp.) obtained by cultivating I.